E. Charalambous

发表

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

R. Wirtz, W. Grady, G. Fountzilas, 2017, Clinical Epigenetics.

Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.

A. Adamou, K. Kyriacou, S. Neuhausen, 2004, Cancer genetics and cytogenetics.

BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer

A. Adamou, K. Kyriacou, A. Hadjisavvas, 2003, Human mutation.

Evaluation of Two Highly-Multiplexed Custom Panels for Massively Parallel Semiconductor Sequencing on Paraffin DNA

K. Papadopoulou, G. Fountzilas, Z. Alexopoulou, 2015, PloS one.

Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics

Andigoni Malousi, George Fountzilas, A. Malousi, 2009, PloS one.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

H. Gogas, G. Aravantinos, A. Psyrri, 2016, Journal of Translational Medicine.

A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.

V. Kotoula, I. Kostopoulos, T. Koletsa, 2008, Neoplasia.

Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group

N. Pavlidis, T. Ciuleanu, K. Papadopoulou, 2014, Clinical & Experimental Metastasis.

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

N. Munshi, D. McMillin, P. Richardson, 2009, Clinical Cancer Research.

Adjusting Breast Cancer Patient Prognosis with Non-HER2-Gene Patterns on Chromosome 17

H. Gogas, C. Papadimitriou, G. Aravantinos, 2014, PloS one.

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study

H. Gogas, G. Aravantinos, K. Papadopoulou, 2015, PloS one.

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

N. Pavlidis, G. Fountzilas, G. Pentheroudakis, 2014, BMC Cancer.

Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.

G. Fountzilas, G. Pentheroudakis, C. Dervenis, 2016, Anticancer research.

The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.

K. Papadopoulou, G. Fountzilas, K. Kamposioras, 2013, Anticancer research.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

H. Gogas, G. Aravantinos, A. Psyrri, 2016, Journal of Translational Medicine.

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

N. Mitsiades, C. Mitsiades, G. Voutsinas, 2006, The Journal of clinical endocrinology and metabolism.

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

R. Wirtz, W. Grady, G. Fountzilas, 2017, Clinical Epigenetics.

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.

M. Dimopoulos, G. Fountzilas, G. Pentheroudakis, 2014, Clinical breast cancer.

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.

M. Dimopoulos, G. Fountzilas, G. Pentheroudakis, 2014, Clinical breast cancer.